Regulatory agencies like the FDA and EPA are actively involved in evaluating the safety of nanomaterials. They provide guidelines for the development and use of nanotechnology in medicine, ensuring that the benefits outweigh the risks. Continuous monitoring and research are essential for updating these guidelines.
